ArticleCancer gene therapy2001

Inhibitory effects of the combination of HER-2 antisense oligonucleotide and chemotherapeutic agents used for the treatment of human breast cancer.

A S Rait et al.PubMed ↗Publisher ↗

No numbers read from the abstract.